Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(7 sites)
United States
NEO-811 Grand Rapids Site, Grand Rapids, Michigan NEO-811 Long Island Site, Lake Success, New York NEO-811-101 NYC Site, New York, New York NEO-811 South Carolina Site, Myrtle Beach, South Carolina NEO-811 Dallas Site, Dallas, Texas NEO-811 Houston Site, Houston, Texas NEO-811 Virginia Site, Fairfax, Virginia